Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Sweden Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20157
20162
20171
20195
20202
20211
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Terminated4
Unknown status3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Uppsala University3
Karolinska University Hospital2
Eli Lilly and Company1
Genfit1
Hanns-Ulrich Marschall1
Helsinki University Central Hospital1
Intercept Pharmaceuticals1
Linkoeping University1
Marja-Riitta Taskinen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease24
Obesity7
Diabetes Mellitus, Type 25
Fatty Liver5
Liver Cirrhosis3
Dyslipidemias2
Fibrosis2
Insulin Resistance2
Weight Loss2
Atherosclerosis1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.